{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T11:06:15Z","timestamp":1791198375880,"version":"4.1.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2010,9,14]],"date-time":"2010-09-14T00:00:00Z","timestamp":1284422400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acta Neuropathol"],"published-print":{"date-parts":[[2010,11]]},"DOI":"10.1007\/s00401-010-0741-7","type":"journal-article","created":{"date-parts":[[2010,9,13]],"date-time":"2010-09-13T04:36:47Z","timestamp":1284352607000},"page":"641-649","source":"Crossref","is-referenced-by-count":162,"title":["Glucocerebrosidase is present in \u03b1-synuclein inclusions in Lewy body disorders"],"prefix":"10.1007","volume":"120","author":[{"given":"Ozlem","family":"Goker-Alpan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara K.","family":"Stubblefield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benoit I.","family":"Giasson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen","family":"Sidransky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,9,14]]},"reference":[{"key":"741_CR1","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1056\/NEJMoa033277","volume":"351","author":"J Aharon-Peretz","year":"2004","unstructured":"Aharon-Peretz J, Rosenbaum H, Gershoni-Baruch R (2004) Mutations in the glucocerebrosidase gene and Parkinson\u2019s disease in Ashkenazi Jews. N Engl J Med 351:1972\u20131977","journal-title":"N Engl J Med"},{"key":"741_CR2","first-page":"879","volume":"152","author":"M Baba","year":"1998","unstructured":"Baba M, Nakajo S, Tu PH et al (1998) Aggregation of alpha-synuclein in Lewy bodies of sporadic Parkinson\u2019s disease and dementia with Lewy bodies. Am J Pathol 152:879\u2013884","journal-title":"Am J Pathol"},{"key":"741_CR3","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","volume":"24","author":"H Braak","year":"2003","unstructured":"Braak H, Del Tredici K, Rub U et al (2003) Staging of brain pathology related to sporadic Parkinson\u2019s disease. Neurobiol Aging 24:197\u2013211","journal-title":"Neurobiol Aging"},{"key":"741_CR4","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1016\/j.neurobiolaging.2007.11.016","volume":"30","author":"J Bras","year":"2009","unstructured":"Bras J, Paisan-Ruiz C, Guerreiro R et al (2009) Complete screening for glucocerebrosidase mutations in Parkinson disease patients from Portugal. Neurobiol Aging 30:1515\u20131517","journal-title":"Neurobiol Aging"},{"key":"741_CR5","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1001\/archneurol.2009.54","volume":"66","author":"LN Clark","year":"2009","unstructured":"Clark LN, Kartsaklis LA, Wolf Gilbert R et al (2009) Association of glucocerebrosidase mutations with dementia with Lewy bodies. Arch Neurol 66:578\u2013583","journal-title":"Arch Neurol"},{"key":"741_CR6","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1126\/science.1101738","volume":"305","author":"AM Cuervo","year":"2004","unstructured":"Cuervo AM, Stefanis L, Fredenburg R, Lansbury PT, Sulzer D (2004) Impaired degradation of mutant alpha-synuclein by chaperone-mediated autophagy. Science 305:1292\u20131295","journal-title":"Science"},{"key":"741_CR7","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1093\/jnen\/59.9.830","volume":"59","author":"JE Duda","year":"2000","unstructured":"Duda JE, Giasson BI, Gur TL et al (2000) Immunohistochemical and biochemical studies demonstrate a distinct profile of \u03b1-synuclein permutations in multiple system atrophy. J Neuropathol Exp Neurol 59:830\u2013841","journal-title":"J Neuropathol Exp Neurol"},{"key":"741_CR8","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1006\/exnr.2000.7527","volume":"166","author":"WP Gai","year":"2000","unstructured":"Gai WP, Yuan HX, Li XQ et al (2000) In situ and in vitro study of colocalization and segregation of alpha-synuclein, ubiquitin, and lipids in Lewy bodies. Exp Neurol 166:324\u2013333","journal-title":"Exp Neurol"},{"key":"741_CR9","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1212\/01.wnl.0000304039.11891.29","volume":"70","author":"Z Gan-Or","year":"2008","unstructured":"Gan-Or Z, Giladi N, Rozovski U et al (2008) Genotype-phenotype correlations between GBA mutations and Parkinson disease risk and onset. Neurology 70:2277\u20132283","journal-title":"Neurology"},{"key":"741_CR10","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1038\/35081564","volume":"2","author":"M Goedert","year":"2001","unstructured":"Goedert M (2001) Alpha-synuclein and neurodegenerative diseases. Nat Rev Neurosci 2:492\u2013501","journal-title":"Nat Rev Neurosci"},{"key":"741_CR11","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1212\/01.wnl.0000230215.41296.18","volume":"67","author":"O Goker-Alpan","year":"2006","unstructured":"Goker-Alpan O, Giasson BI, Eblan MJ et al (2006) Glucocerebrosidase mutations are an important risk factor for Lewy body disorders. Neurology 67:908\u2013910","journal-title":"Neurology"},{"key":"741_CR12","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1001\/archneur.65.10.1353","volume":"65","author":"O Goker-Alpan","year":"2008","unstructured":"Goker-Alpan O, Lopez G, Vithayathil J et al (2008) The spectrum of parkinsonian manifestations associated with glucocerebrosidase mutations. Arch Neurol 65:1353\u20131357","journal-title":"Arch Neurol"},{"key":"741_CR13","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1136\/jmg.2004.024455","volume":"41","author":"O Goker-Alpan","year":"2004","unstructured":"Goker-Alpan O, Schiffmann R, LaMarca ME et al (2004) Parkinsonism among Gaucher disease carriers. J Med Genet 41:937\u2013940","journal-title":"J Med Genet"},{"key":"741_CR14","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1194\/jlr.M800092-JLR200","volume":"49","author":"LK Hein","year":"2008","unstructured":"Hein LK, Duplock S, Hopwood JJ, Fuller M (2008) Lipid composition of microdomains is altered in a cell model of Gaucher disease. J Lipid Res 49:1725\u20131734","journal-title":"J Lipid Res"},{"key":"741_CR15","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1136\/jnnp.55.3.181","volume":"55","author":"AJ Hughes","year":"1992","unstructured":"Hughes AJ, Daniel SE, Kilford L, Lees AJ (1992) Accuracy of clinical diagnosis of idiopathic Parkinson\u2019s disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 55:181\u2013184","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"741_CR16","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.ymgme.2003.11.004","volume":"81","author":"A Lwin","year":"2004","unstructured":"Lwin A, Orvisky E, Goker-Alpan O, LaMarca ME, Sidransky E (2004) Glucocerebrosidase mutations in subjects with parkinsonism. Mol Genet Metab 81:70\u201373","journal-title":"Mol Genet Metab"},{"key":"741_CR17","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1212\/01.wnl.0000187889.17253.b1","volume":"65","author":"IG McKeith","year":"2005","unstructured":"McKeith IG, Dickson DW, Lowe J et al (2005) Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology 65:1863\u20131872","journal-title":"Neurology"},{"key":"741_CR18","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1001\/archneurol.2009.72","volume":"66","author":"J Mitsui","year":"2009","unstructured":"Mitsui J, Mizuta I, Toyoda A et al (2009) Mutations for Gaucher disease confer high susceptibility to Parkinson disease. Arch Neurol 66:571\u2013576","journal-title":"Arch Neurol"},{"key":"741_CR19","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1093\/brain\/awp044","volume":"132","author":"J Neumann","year":"2009","unstructured":"Neumann J, Bras J, Deas E et al (2009) Glucocerebrosidase mutations in clinical and pathologically proven Parkinson\u2019s disease. Brain 132:1783\u20131794","journal-title":"Brain"},{"key":"741_CR20","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1212\/01.wnl.0000327823.81237.d1","volume":"72","author":"WC Nichols","year":"2009","unstructured":"Nichols WC, Pankratz N, Marek DK et al (2009) Mutations in GBA are associated with familial Parkinson disease susceptibility and age at onset. Neurology 72:310\u2013316","journal-title":"Neurology"},{"key":"741_CR21","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0070-2153(04)60002-0","volume":"60","author":"EH Norris","year":"2004","unstructured":"Norris EH, Giasson BI, Lee VM (2004) Alpha-synuclein: normal function and role in neurodegenerative diseases. Curr Top Dev Biol 60:17\u201354","journal-title":"Curr Top Dev Biol"},{"key":"741_CR22","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/S1096-7192(02)00117-8","volume":"76","author":"E Orvisky","year":"2002","unstructured":"Orvisky E, Park JK, LaMarca ME et al (2002) Glucosylsphingosine accumulation in tissues from patients with Gaucher disease: correlation with phenotype and genotype. Mol Genet Metab 76:262\u2013270","journal-title":"Mol Genet Metab"},{"key":"741_CR23","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1126\/science.276.5321.2045","volume":"276","author":"MH Polymeropoulos","year":"1997","unstructured":"Polymeropoulos MH, Lavedan C, Leroy E et al (1997) Mutation in the alpha-synuclein gene identified in families with Parkinson\u2019s disease. Science 276:2045\u20132047","journal-title":"Science"},{"key":"741_CR24","doi-asserted-by":"crossref","first-page":"3386","DOI":"10.1021\/bi052344d","volume":"45","author":"M Ramakrishnan","year":"2006","unstructured":"Ramakrishnan M, Jensen PH, Marsh D (2006) Association of alpha-synuclein and mutants with lipid membranes: spin-label ESR and polarized IR. Biochemistry 45:3386\u20133395","journal-title":"Biochemistry"},{"key":"741_CR25","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1177\/002215549904700211","volume":"47","author":"HJ Romijn","year":"1999","unstructured":"Romijn HJ, van Uum JF, Breedijk I et al (1999) Double immunolabeling of neuropeptides in the human hypothalamus as analyzed by confocal laser scanning fluorescence microscopy. J Histochem Cytochem 47:229\u2013236","journal-title":"J Histochem Cytochem"},{"key":"741_CR26","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1002\/mds.20319","volume":"20","author":"C Sato","year":"2005","unstructured":"Sato C, Morgan A, Lang AE et al (2005) Analysis of the glucocerebrosidase gene in Parkinson\u2019s disease. Mov Disord 20:367\u2013370","journal-title":"Mov Disord"},{"key":"741_CR27","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1073\/pnas.0509567103","volume":"103","author":"CW Shults","year":"2006","unstructured":"Shults CW (2006) Lewy bodies. Proc Natl Acad Sci USA 103:1661\u20131668","journal-title":"Proc Natl Acad Sci USA"},{"key":"741_CR28","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1056\/NEJMoa0901281","volume":"361","author":"E Sidransky","year":"2009","unstructured":"Sidransky E, Nalls MA, Aasly JO et al (2009) Multicenter analysis of glucocerebrosidase mutations in Parkinson\u2019s disease. N Engl J Med 361:1651\u20131661","journal-title":"N Engl J Med"},{"key":"741_CR29","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/42166","volume":"388","author":"MG Spillantini","year":"1997","unstructured":"Spillantini MG, Schmidt ML, Lee VM et al (1997) Alpha-synuclein in Lewy bodies. Nature 388:839\u2013840","journal-title":"Nature"},{"key":"741_CR30","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1203\/00006450-199805000-00003","volume":"43","author":"N Tayebi","year":"1998","unstructured":"Tayebi N, Reissner KJ, Lau EK et al (1998) Genotypic heterogeneity and phenotypic variation among patients with type 2 Gaucher\u2019s disease. Pediatr Res 43:571\u2013578","journal-title":"Pediatr Res"},{"key":"741_CR31","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/S1096-7192(03)00071-4","volume":"79","author":"N Tayebi","year":"2003","unstructured":"Tayebi N, Walker J, Stubblefield B et al (2003) Gaucher disease with parkinsonian manifestations: does glucocerebrosidase deficiency contribute to a vulnerability to parkinsonism? Mol Genet Metab 79:104\u2013109","journal-title":"Mol Genet Metab"},{"key":"741_CR32","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.ymgme.2004.04.011","volume":"82","author":"K Wong","year":"2004","unstructured":"Wong K, Sidransky E, Verma A et al (2004) Neuropathology provides clues to the pathophysiology of Gaucher disease. Mol Genet Metab 82:192\u2013207","journal-title":"Mol Genet Metab"},{"key":"741_CR33","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.ymgme.2007.03.004","volume":"91","author":"SG Ziegler","year":"2007","unstructured":"Ziegler SG, Eblan MJ, Gutti U et al (2007) Glucocerebrosidase mutations in Chinese subjects from Taiwan with sporadic Parkinson disease. Mol Genet Metab 91:195\u2013200","journal-title":"Mol Genet Metab"}],"container-title":["Acta Neuropathologica"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00401-010-0741-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00401-010-0741-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00401-010-0741-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T17:24:09Z","timestamp":1559064249000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00401-010-0741-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,9,14]]},"references-count":33,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2010,11]]}},"alternative-id":["741"],"URL":"https:\/\/doi.org\/10.1007\/s00401-010-0741-7","relation":{},"ISSN":["0001-6322","1432-0533"],"issn-type":[{"value":"0001-6322","type":"print"},{"value":"1432-0533","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,9,14]]}}}